ICOS Corporation
22021 20th Avenue S.E.
Bothell
Washington
98021
United States
Tel: 425-485-1900
Fax: 425-489-0356
Website: http://www.icos.com/
Email: info@icos.com
24 articles about ICOS Corporation
-
Eli Lilly and Company Announces Completion Of ICOS Corporation Acquisition
1/30/2007
-
ICOS Corporation Special Meeting Adjourned And Scheduled To January 25, 2007
12/19/2006
-
ICOS Corporation Reports Net Income Of $9.7 Million, Fifteen Cents Per Share, For 2006 Third Quarter
11/3/2006
-
Eli Lilly and Company To Acquire ICOS Corporation For $2.1 Billion
10/17/2006
-
ICOS Corporation To Participate In The UBS Warburg Global Life Sciences Conference
9/15/2006
-
ICOS Corporation To Participate In The Thomas Weisel Partners Healthcare Conference
8/24/2006
-
ICOS Corporation Reports Net Income Of $6.1 Million, Nine Cents Per Share, For 2006 Second Quarter; 2006 Expected To Be First Profitable Year In Company's History
8/4/2006
-
ICOS Corporation To Release Financial Results For 2006 Second Quarter On August 3, 2006
7/20/2006
-
Dyax Corp. And ICOS Corporation Enter Into License Agreement For Discovery Of Therapeutic Antibodies
5/22/2006
-
ICOS Corporation Reports Results For 2006 First Quarter
5/5/2006
-
ICOS Corporation To Release Financial Results For 2006 First Quarter On May 4, 2006
4/25/2006
-
ICOS Corporation To Participate In Upcoming Healthcare Conference
2/23/2006
-
ICOS Corporation Reports Net Income Of $5.6 million ($0.09 Per Share) For 2005 Fourth Quarter
2/8/2006
-
ICOS Corporation To Participate In Upcoming Investment Conference
1/24/2006
-
ICOS Corporation To Release 2005 Financial Results On February 7, 2006
1/23/2006
-
Caprion Pharmaceuticals Announces Biomarker Discovery Collaboration With ICOS Corporation
1/18/2006
-
ICOS Corporation To Participate In Upcoming Investment Conference
12/28/2005
-
ICOS Corporation Reports Results For 2005 Third Quarter; Lilly ICOS LLC Achieved First Quarterly Profit In Its History; Positive Results From Phase 2 Study Of Tadalafil To Treat Symptoms Of BPH
11/4/2005
-
ICOS Corporation To Release Financial Results For 2005 Third Quarter On November 3, 2005
10/20/2005
-
FDA To Review P&G Female Sex Dysfunction Drug
12/1/2004